Evidence both L-type and non-L-type voltage-dependent calcium channels contribute to cerebral artery vasospasm following loss of NO in the rat  by McNeish, A.J. et al.
Vascular Pharmacology 53 (2010) 151–159
Contents lists available at ScienceDirect
Vascular Pharmacology
j ourna l homepage: www.e lsev ie r.com/ locate /vphEvidence both L-type and non-L-type voltage-dependent calcium channels
contribute to cerebral artery vasospasm following loss of NO in the rat
A.J. McNeish b, Francesc Jimenez Altayo a, C.J. Garland a,⁎
a Department of Pharmacology, University of Oxford, Mansﬁeld Road Oxford OX1 3QT, United Kingdom
b Department of Pharmacy and Pharmacology, University of Bath, BA2 7AY, United Kingdom⁎ Corresponding author. Tel.: +44 1865 281119; fax:
E-mail address: christopher.garland@pharm.ox.ac.uk
1537-1891© 2010 Elsevier Inc.
doi:10.1016/j.vph.2010.06.002
Open access under CC BY a b s t r a c ta r t i c l e i n f oArticle history:
Received 21 April 2010
Received in revised form 1 June 2010
Accepted 12 June 2010
Keywords:
Cerebral vasospasm
K-channels
T-type calcium channels
Nitric oxide
Endothelial cell dysfunctionWerecently found block of NO synthase in ratmiddle cerebral artery caused spasm, associatedwith depolarizing
oscillations inmembrane potential (Em) similar in formbut faster in frequency (circa 1 Hz) to vasomotion. T-type
voltage-gated Ca2+ channels contribute to cerebral myogenic tone and vasomotion, so we investigated the
signiﬁcance of T-type and other ion channels for membrane potential oscillations underlying arterial spasm.
Smoothmuscle cell membrane potential (Em) and tension were measured simultaneously in rat middle cerebral
artery. NO synthase blockade caused temporally coupled depolarizing oscillations in cerebrovascular Em with
associated vasoconstriction. Both events were accentuated by block of smooth muscle BKCa. Block of T-type
channels or inhibition of Na+/K+-ATPase abolished the oscillations in Em and reduced vasoconstriction.
Oscillations in Emwere either attenuated or accentuated by reducing [Ca2+]o or block of KV, respectively. TRAM-
34 attenuated oscillations in both Em and tone, apparently independent of effects against KCa3.1. Thus, rapid
depolarizing oscillations in Em and tone observed after endothelial functionhas beendisrupted reﬂect input from
T-type calcium channels in addition to L-type channels, while other depolarizing currents appear to be
unimportant. These data suggest that combined block of T and L-type channels may represent an effective
approach to reverse cerebral vasospasm.+44 1865 271853.
(C.J. Garland).
license. © 2010 Elsevier Inc. Open access under CC BY license. 1. Introduction
Cerebral arteries operate in a dynamic state of partial constriction
(myogenic tone), providing the capacity to constrict or relax in
response to changing levels of intraluminal pressure, shear stress and
nerve activity. Myogenic tone is an intrinsic property of the smooth
muscle, helping maintain constant total cerebral blood ﬂow and
adapting blood ﬂow locally to meet metabolic demand. Myogenic
constriction is driven primarily by membrane depolarization leading
to Ca2+ inﬂux (Davis and Hill, 1999; Hill et al., 2001), possibly with a
contribution via stretch-activated calcium sensitization (Schubert et
al., 2008). Myogenic tone is often superimposed by vasomotion in the
form of synchronised oscillations in smooth muscle cell membrane
potential (Em), Ca2+ and tension. Although the physiological function
of vasomotion in general is unclear, it may help to maintain a constant
blood supply in many tissues, including the brain (Gustafsson, 1993;
Haddock and Hill, 2005).
One key inﬂuence of basal NO release in the middle cerebral artery
appears to be suppression of bothmyogenic tone (Golding et al., 2001;
Peng et al., 1998; Zimmermann et al., 1997) and vasomotion (Dirnagl
et al., 1993; Haddock and Hill, 2002). This inﬂuence appears largelydue to activation of BKCa (Brayden and Nelson, 1992; Mandala et al.,
2007; Yuill et al., 2010). So block of NO generation and/or BKCa
provides ameans tomimic an aspect of endothelial dysfunction that is
an early feature of cardiovascular disease, including disease conditions
that predispose to vasospasm (Jewell et al., 2004; Vanhoutte et al.,
2009). These conditions will also mimic the loss of NO observed after
subarachnoid haemorrhage, where scavenging of NO by haemoglobin
(Martin et al., 1985) causes profound vasospasm (Toda et al., 1991).
Signiﬁcantly, enhanced vasomotion (or vasospasm) can lead to a
reduction of cerebral capillary blood ﬂow and thus compromise of
neuronal function (Biswal and Hudetz, 1996; Pluta, 2005).
Several mechanisms, including the rho-kinase pathway, can con-
tribute to the development and maintenance of constriction in smooth
muscle, alongside calcium entry. However, in many vascular beds,
including the cerebral vasculature changes in smooth muscle intracel-
lular Ca2+ ([Ca2+]i) concentration is critical for myogenic tone and
vasomotion (Haddock and Hill, 2002, 2005; Yuill et al., 2010). [Ca2+]i
increase involves release from intracellular stores and entry from the
extracellular space via voltage-gated Ca2+ channels and non-selective
cation channels, such as transient receptor potential channels (TRPC).
Ca2+ inﬂux throughvoltage-gatedCa2+ channels (VGCC) leads toglobal
increases in smooth muscle cell [Ca2+]i and constriction, and high
voltage activated (L-type)Ca2+channels appear central in this sequence
(McCarron et al., 1997; Moosmang et al., 2003; Nelson et al., 1990).
These channels are expressed widely in vascular smooth muscle and
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(circa−50 to−30 mV) (Lacinova, 2005; Smirnov and Aaronson, 1992).
Low voltage activated or T-type Ca2+ channels are also expressed in
vascular smooth muscle of resistance arteries (Braunstein et al., 2008;
Clozel et al., 1997; Kuo et al., 2008;Navarro-Gonzalez et al., 2009; Perez-
Reyes, 2003). But although they are normally active in the range circa
−60 to−40 mV, the characteristic rapid inactivation of these channels
argues against a signiﬁcant role at physiologically relevant membrane
potentials in the vasculature. Despite this, they have been implicated in
the maintenance of vascular tone in a variety of arteries, including rat
cremaster (VanBavel et al., 2002), rat basilar (Navarro-Gonzalez et al.,
2009) and middle cerebral (Lam et al., 1998) arteries, and direct
measurements have shown high voltage activated but nifedipine-
insensitive Ca2+ currents, pharmacologically indistinguishable from T-
type currents, in both guinea-pig and rat terminal mesenteric arteries
(Gustafsson, 1993; Morita et al., 1999; Morita et al., 2002).
We recently reported thatmiddle cerebral arteries develop intense
and sustained constriction, associated with a very rapid form of
vasomotion, when NOS and/or BKCa channels were blocked, to mimic
endothelial dysfunction. Furthermore, both constriction and vasomo-
tion depended on calcium entry via VGCCs and the oscillations in Em
were temporally linked to changes in smoothmuscle [Ca2+]i (Yuill et al.,
2010). The temporally linkedoscillations inEm, [Ca2+]i and tensionwere
similar to the widely described phenomenon of vasomotion, but
displayed a much higher frequency (∼1 Hz as opposed to ∼0.1–
0.2 Hz, Yuill et al., 2010). The intense “vasospastic vasomotion” was
reversed by inhibition L-type Ca2+ channels and clearly involved a
complex action of NO that appeared to include stimulation of BKCa
channels and a cGMP-independent closure of VGCCs (Yuill et al., 2010).
However, although a central role for VGCC, NO and BKCa was apparent,
the importance of other ionic currents thatmight contribute to the rapid
depolarizing oscillations was unclear.
Thus, the aim of the present study was to characterize the ionic
mechanisms responsible for rhythmic oscillations in Em and tension in
rat isolated middle cerebral arteries following inhibition of BKCa
channels and NOS. We probed channels that may lead to both
depolarization (calcium, sodium and chloride channels) and repolari-
zation (potassium channels). Our data suggest a novel role for both
smooth muscle T-type Ca2+ channels and several potassium conduc-
tances in the both “vasospastic vasomotion” and the underlying
maintenance of vasoconstriction.
2. Materials and methods
2.1. Animals and tissue isolation
Male Wistar rats (200–250 g) were killed by cervical dislocation
followed by decapitation, following institutional guidelines for animal
welfare and schedule 1 of the Animals (scientiﬁc procedures) Act
1986. The brain was removed and immediately placed in ice-cold
Krebs solution. Segments of the middle cerebral artery (∼2 mm long)
were dissected and stored in ice-cold Krebs for use within 30 min,
with similar size vessels used in all experimental groups.
2.2. Experimental protocols
Segments of middle cerebral artery (internal diameter ∼150 μm)
were mounted in a Mulvany–Halpern myograph (model 400A, Danish
Myotechnology) in Krebs solution containing (mM): NaCl, 118.0,
NaCO3, 24; KCl, 3.6; MgSO4·7H2O, 1.2; glucose, 11.0; CaCl2, 2.5; gassed
with 20% O2, 5% CO2 and balance N2 and maintained at 37 °C. After
equilibration for 20 min, vessels were tensioned to 1–1.5 mN (approx-
imateswall tension at 60 mmHg). Smoothmuscle tensionwas recorded
with an isometric force transducer and Powerlab software (ADI,
Australia). Vessel viability was assessed by addition of exogenous K+
(15–55 mM, total K+ concentration); only vessels developing tension of≥3 mNwere used, following this Endothelial cell viability was assessed
by the ability of the protease activated receptor 2 activating peptide;
SLIGRL (20 μM) (Alexander et al., 2008) to relax U46619 induced tone
(100 nM) by≥75%, vesselswith less relaxationwere discarded. In some
experiments, endothelial cells were removed by gently rubbing the
luminal surface with a human hair; subsequent relaxation of b15% to
SLIGRL (20 μM) was considered as successful removal and further
abrasion often lead to damage of smooth muscle cells.
L-NAME (100 μM), indomethacin (10 μM) and iberiotoxin
(100 nM) were added throughout the experiment (to block NO
synthase (NOS), cyclooxygenase and BKCa channels, respectively),
unless otherwise stated. In combination, these drugs gave a robust
and sustained constriction (similar to vasospasm), and an associated
rapid vasomotion. Similar responses were recorded in each case after
inhibition of NOS alone, but vasomotion was more variable between
preparations. Indomethacin had no effect on oscillations, but was
included in the experimental cocktail to minimize any potential for
confounding thromboxane signaling after NOS inhibition (Benyo et al.,
1998; McNeish and Garland, 2007). Recordings were assessed in the
presence of: the T-type (mibefradil 100 nM and NNC 55-0396
300 nM) and L-type (nifedipine 1 μM) Ca2+channel blockers, the
KCa channel blockers, apamin (KCa2.3 (SKCa), 50 nM), TRAM-34
(KCa3.1 (IKCa), 1 μM), iberiotoxin (BKCa, KCa1.1, 100 nM) and char-
ybdotoxin (KCa3.1, BCa, 100 nM), the KIR channel inhibitors BaCl2
(30 μM) and CsCl2 (10 mM), the Na+/K+-ATPase inhibitor, ouabain
(1 μM) and the voltage-gated K+ channel inhibitor, 4-aminopyridine
(4-AP, 3 mM). Papaverine (150 μM) was added at the end of each
experiment to assess overall tone. All blocking drugs were incubated
for at least 20 min before data was recorded to ensure maximal effect.
In most experiments smooth muscle membrane potential (Em) and
tension were measured simultaneously as previously described, using
glassmicroelectrodes (ﬁlledwith 2 MKCl; tip resistance, 80–120 MΩ)
to measure Em (Garland and McPherson, 1992).
2.3. Data analysis and statistical procedures
Results are expressed as the mean±s.e. mean of n animals. Tension
values are given in mN (always per 2 mm segment) and Em as mV.
During the vasospastic vasomotion Em is expressed as themean Em over
a random 10 s period of the rapid vasomotion where possible we have
also reported the size of the depolarizing oscillations in mV. Vasodila-
tation is expressed as percentage reduction of the total vascular tone
(myogenic tone plus vasoconstrictor response induced by either
U46619 or the combination of L-NAME and iberiotoxin, as appropriate),
quantiﬁed by relaxationwith papaverine (150 μM). Graphswere drawn
and comparisonsmadeusing either Student's t-test, or one-wayANOVA
with Tukey's post-hoc test using Prism software (Graphpad, USA).
P≤0.05 was considered signiﬁcant.
2.4. Drugs, chemicals, reagents and other materials
Exogenous K+ was added as an isotonic physiological salt
solution in which all the NaCl was replaced with an equivalent
amount of KCl. Concentrations of K+ used are expressed as ﬁnal bath
concentration. L-NAME (NG-nitro-L-arginine methyl ester), indo-
methacin, mibefradil, NNC 55-0396, nifedipine, barium chloride,
cesium chloride, ouabain, 4-aminopyridine and papaverine were all
obtained from Sigma (Poole, U.K.). U46619 (9,11-Dideoxy-11α,9α-
epoxymethanoprostaglandin F2α) was from Calbiochem (UK).
Apamin, charybdotoxin, iberiotoxin and tetrodotoxin from Latoxan
(Valence, France). SLIGRL (serine–leucine–isoleucine–glycine–argi-
nine–leucine–NH2) from Auspep (Parkville, Australia). TRAM-34
was a generous gift fromDr H.Wulff (University of California, Davis).
All stock solutions were dissolved in distilled water except SLIGRL
and charybdotoxin, dissolved in 0.9% NaCl, U46619 and TRAM-34,
dissolved in dimethylsulfoxide (DMSO), nifedipine, dissolved in
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vehicle controls were performed for drugs dissolved in DMSO
ethanol and Na2CO3. All nomenclature conforms to the BJP guide to
receptors and ion channels (Alexander et al., 2008).3. Results
3.1. Effect of inhibiting Nitric oxide synthase and BKCa on Em and tension.
Rat middle cerebral arteries developed spontaneous myogenic tone
equivalent to1.3±0.1 mN(≈15%ofmaximumtension,with55 mmol/L
KCl, n=40) with a restingmembrane potential (Em) of−42.1±0.9 mV
(n=40). Addition of the NOS inhibitor, L-NAME (100 μM), and the
cyclooxygenase inhibitor, indomethacin (10 μM) tended to evoke
smooth muscle cell depolarization (Em −39.2±1.0 mV, n=38) and
constriction (4.6±0.2 mN, n=40; Pb0.05). In all vessels, the depolar-
ization developed into ongoing oscillations (amplitude 7±0.9 mV)
followed by equivalent changes in tone (amplitude 0.12±0.01 mN).We
have previously reported similar observations in the rat middle cerebral
artery following NOS inhibition alone (Yuill et al., 2010). With L-NAME
present, stimulation of the endothelium with 20 μM SLIGRL evoked
hyperpolarization of 20.9±1.7 mV (n=31) associated with 77.6±3.6%
relaxation (n=37).
In the presence of L-NAME and indomethacin, the BKCa channel
inhibitor, iberiotoxin (100 nM), evoked further depolarization (to Em
−35.7±1.1 mV, n=40; Pb0.05) and constriction (to 5.7±0.2 mN,
n=41; Pb0.05), associated with a marked increase in the amplitude of
oscillations in Em temporally linked to tension (Fig. 1B). The oscillations
in Em and tension had a frequency of 0.84±0.02 Hz and 0.80±0.05 Hz
and amplitude of 22.6±1.3 mV and 0.19±0.02 mN, respectively
(n=41). All subsequent experiments were performed in the presence
of L-NAME, indomethacin and iberiotoxin unless stated. Removal of theFig. 1. Original traces showing simultaneous recordings of membrane potential (upper pa
conditions (A) or in the presence of L-NAME (100 μM), indomethacin (10 μM) and iberiotoxi
stable. In the presence of L-NAME, indomethacin and iberiotoxin, the smooth muscle cells d
constriction and oscillations in tension; the peaks in membrane potential immediately prece
depolarization and relaxation. Average data are shown in (C and D) showing the oscillation
and in the presence of 1, 0.5, 0.25 and 0 mM Ca2+. Data expressed as means±S.E.M. * P≤0.0
hoc test, n=3–7.endothelium abolished SLIGRL-mediated relaxation (20 μM), but failed
to affect oscillations in Em (frequency of 0.76±0.10 Hz; amplitude of
19.4±4.3 mV) and tension (frequency of 0.66±0.10 Hz; amplitude of
0.16±0.05 mN, n=3).
3.2. [Ca2+]o but not Na
+ or Cl− currents modify oscillations in
membrane potential
The voltage-dependent Na+ channel blocker, tetrodotoxin (1 μM)
did not modify either the frequency or amplitude of oscillations in Em
(control: frequency of 0.84±0.03 Hz, amplitude of 16.1±1.4 mV;
tetrodotoxin: frequency of 0.90±0.02 Hz, amplitude of 15.4±2.7 mV,
n=3) and tension (control: frequency of 0.73±0.11 Hz, amplitude of
0.13±0.01 mN; tetrodotoxin: frequencyof 0.67±0.14 Hz, amplitudeof
0.12±0.01 mN, n=3).
To investigate if the oscillations were dependent upon Ca2+ inﬂux,
we decreased extracellular Ca2+ in steps from 2.5 to 0 mM. Simulta-
neous measurements of changes in Em and tension showed that
decreasing Ca2+ evoked depolarization (from −37.0±2.1 to −26.8±
2.4 mV, n=7; Pb0.05) and relaxation (from 5.4±0.6 to 0.3±0.1 mN,
n=7; Pb0.05). Under these conditions, the amplitude of oscillations in
Em and tensionwas diminished (Fig. 1C and D). The calcium-dependent
Cl− channel inhibitor, DIDS (150 μM), did not alter spontaneous
oscillations in Em or tension (data not shown) nor did it modify Em
(control: −44.4±3.0 mV; DIDS: −49.2±3.9 mV, n=5) or tension
(control: 4.7±0.6 mN; DIDS: 3.6±0.5 mN, n=5).
3.3. Effect of Ca2+channel blockers on oscillations in Em and tension
The T-type selective Ca2+ channel blocker, mibefradil (100 nM)
abolished oscillations in Em (Fig. 2A), signiﬁcantly reduced oscillations
in tension (control: frequency of 0.79±0.07 Hz, amplitude of 0.16±nels) and tension (lower panels) in rat middle cerebral arteries under control resting
n (100 mN; B). Under control conditions, membrane potential and tension are relatively
epolarized and developed regular depolarizing oscillations, which were associated with
ded peaks in tension. Decreasing extracellular calcium (from 2.5 to 0 mM Ca2+) caused
amplitude in membrane potential (C) and tension (D) in control vessels (2.5 mM Ca2+)
5 indicates a signiﬁcant difference from control by one-way ANOVA with Tukey's post-
Fig. 2. Original traces showing the effect of either (A) the T-type Ca2+ channel blocker, mibefradil (100 nM), (B) the more selective T-type Ca2+ channel antagonist, NNC 55-0396
(300 nM) or (C) the combined application of NNC 55-0396 (300 nM) and the L-type Ca2+ channel blocker, nifedipine (1 μM), on simultaneous recordings of membrane potential
(upper panels) and tension (lower panels). Both mibefradil and NNC 55-0396 caused relaxation and abolished oscillations inmembrane potential and tension; combined application
of NNC 55-0396 and nifedipine caused greater hyperpolarization and relaxation than NNC-550396 alone, n=4–6. Parallel lines (//) indicate a time break between same recordings
from a single vessel the ﬁrst time break shows the response at approximately 5 min post addition of drug the second time break corresponds to the maximum response which is
approximately 15 min following addition.
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0.02 mN, n=5; Pb0.05) and evoked relaxation (control: 5.1±0.7 mN;
mibefradil: 3.5±0.6 mN,n=5)anddepolarization (Emcontrol:−36.1±
1.3 mV; Em mibefradil: −30.4±2.5 mV, n=5). The more selective T-
type Ca2+ channel antagonist, NNC 55-0396 (300 nM) also signiﬁcantly
reduced oscillations in Em (Fig. 2B) and in tension (control: frequency of
0.79±0.09 Hz, amplitude of 0.17±0.03 mN;NNC 55-0396: frequency of
0.20±0.07 Hz, amplitude of 0.07±0.02 mN, n=6; Pb0.05) and evoked
relaxation (control: 5.5±0.5 mN; NNC 55-0396: 3.0±0.5 mN, n=6;
Pb0.05). However, NNC 55-0396 did not signiﬁcantly modify mean Em
(Em control:−36.2±3.2 mV; Em NNC 55-0396:−31.9±3.2 mV, n=6).
Further addition of the L-type voltage-gated Ca2+ channel inhibitor,nifedipine (1 μM), relaxed (control: 5.8±0.7 mN; NNC 55-0396 3.5±
0.6 mN; NNC 55-0396+nifedipine: 0.5±0.1 mN, n=4; Pb0.05) and
hyperpolarized (Em control:−33.0±3.7 mV; EmNNC55-0396:−30.0±
4.6; Em NNC 55-0396+nifedipine:−36.7±3.4 mV, n=4; Fig. 2C). We
also assessed the effect of NNC 55-0396 against middle cerebral artery
basalmyogenic tone in the absence of inhibitors. NNC 55-0396 (300 nM)
did not signiﬁcantly affect Em (Em control: −51.6±2.47; Em NNC 55-
0396: −48.9±2.0 mV, n=5) or relax myogenic tone (control: 1.04±
0.18; NNC 55-0396: 0.69±0.09 mN) under these conditions. The
additional presence of nifedipine (1 μM) also failed to evoke hyperpo-
larization (EmNNC55-0396+nifedipine:−51.5±2.8 mV) but did cause
signiﬁcant relaxation (NNC 55-0396+nifedipine: 0.44±0.04 mN, n=4,
155A.J. McNeish et al. / Vascular Pharmacology 53 (2010) 151–159Pb0.05). We have previously demonstrated similar relaxation of basal
myogenic tone with nifedipine alone (Yuill et al., 2010).
3.4. Involvement of KCa3.1(IKCa) and KCa2.3(SKCa) channels
Addition of the KCa3.1 channel blocker, TRAM-34 (1 μM)markedly
decreased the amplitude of oscillations in Em and tension (Fig. 3B)
followed by small relaxation (control: 6.5±0.4 mN; TRAM-34: 5.3±
0.2 mN, n=5; Pb0.05). TRAM-34 did not signiﬁcantly reduce Em, (Em
control: −33.9±2.6 mV; Em TRAM-34: −28.7±2.3 mV, n=4). The
effect of TRAM-34on the amplitude of oscillations in Em (control: 19.4±
4.3 mV; TRAM-34: 3.0±1.6 mV, n=3; Pb0.05) and tension (control:
0.16±0.05 mN; TRAM-34: 0.04±0.02 mN, n=3) was similar after
endothelium removal. The oscillations in Em and tension were not
modiﬁed by the KCa2.3 blocker apamin (50 nM), either alone (Fig. 3C)
or in the additional presence of TRAM-34 (Fig. 3D). Likewise,
charybdotoxin (100 nM) alone (Fig. 4B) or with apamin (Fig. 4C)
did not affect either oscillations in Em and tension (Fig. 4D and E), or
mean tension and Em.Fig. 3. Original traces showing control conditions (A), the effect of the KCa3.1 channel blocke
application of TRAM-34 and apamin (D) on simultaneous recordings of membrane potentia
membrane potential (left panel) and tension (right panel) in control vessels and in the presen
as means±S.E.M. * P≤0.05 indicates a signiﬁcant difference from control by one-way ANO3.5. Involvement of KIR channels, voltage-gated K
+ channels and the
Na+/K+-ATPase
Inhibition of KIR channels with BaCl2 (30 μM) did not affect the
amplitude of oscillations in Em (control: 31.1±4.6 mV; BaCl2: 30.9±
6.1 mV, n=5) or tension (control: 0.20±0.03 mN; Ba2+: 0.19±
0.03 mV, n=5). However, another inhibitor of KIR, CsCl (10 mM)
increased the amplitude of oscillations in Em (control: 30.8±2.0 mV;
CsCl: 40.4±3.4 mV, n=5; Pb0.05), but not in tension (control: 0.20±
0.02 mN; CsCl: 0.19±0.02 mV, n=5), while 4-aminopyridine (4-AP;
3 mM to block Kv) increased the amplitude of oscillations in both Em
(control: 17.75±2.07; 4-AP: 30.62±7.33 mV, n=3) and tension
(control: 0.17±0.01; 4-AP: 0.25±0.07 mN; n=3, Fig. 5A). The Na+/
K+-ATPase inhibitor, ouabain (1 μM) evoked relaxation (control: 5.8±
0.3 mN; ouabain:4.6±0.2 mN, n=3;Pb0.05) butwithout signiﬁcantly
reducing Em (control: −42.2±1.2 mV; ouabain: −38.4±1.6 mV,
n=3). However, ouabain did reduce both the amplitude (Fig. 5B and
C) and frequency (control: 0.97±0.11 Hz; ouabain: 0.31±0.16 Hz,
n=3; Pb0.05) of oscillations in Em, without altering oscillations inr, TRAM-34 (1 μM; B), the KCa2.3 channel blocker, apamin (50 nM; C) or the combined
l (upper panels) and tension (lower panels). Average data for oscillation amplitude in
ce of TRAM-34, apamin and TRAM-34+apamin are also shown (E). Data are expressed
VA with Tukey's post-hoc test, n=3–9.
Fig. 4. Original traces showing control conditions (A) and the effect of either the BKCa and KCa3.1 channel blocker, charybdotoxin (100 nM; B) or the combined application of
charybdotoxin (100 nM) and the KCa2.3 channel blocker, apamin (50 nM; C) on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Average
data are shown for the oscillation amplitude in membrane potential (D) and tension (E) in control vessels and in the presence of charybdotoxin and charybdotoxin+apamin. Data
expressed as means±S.E.M. n=3–4.
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0.92±0.22 Hz, n=3). The subsequent addition of 4-AP in the presence
of ouabain caused depolarization (ouabain:−38.4±1.6 mV; ouabain+
4-AP: −34.6±3.3 mV, n=3; Pb0.05), and increased oscillations in
Em (Fig. 5C) and increased tension overall (ouabain: 4.6±0.2 mN;
ouabain+4-AP: 5.5±0.2 mN, n=3; Pb0.05).
4. Discussion
This study provides the ﬁrst demonstration, that rhythmic oscilla-
tions inmembrane potential and tension aswell as the associated spasm
in rat isolated middle cerebral arteries following inhibition of BKCa
channels and/or NOS reﬂect Ca2+ inﬂux via T-type Ca2+ channels, in
addition to L-type Ca2+ channels. These data extend our previous
observation that NOS inhibition leads to L-type Ca2+ channel opening
and arterial spasm, characterized by sustained constriction and super-
imposed by rapid vasomotion (Yuill et al., 2010). Vasomotion was of
much higher frequency than previously recorded in other vascular beds,
and as such we refer to it as ‘vasospastic’ vasomotion. We also provide
evidence for modulation of both the Ca2+ dependent vasomotion and
constriction through Na/K ATPase and a K+ conductance.Consistent with previous work, our data suggest that calcium inﬂux
underlies rhythmic oscillations in the constricted rat middle cerebral
artery, and that oscillations inmembranepotential and tensionare linked
to oscillations in intracellular [Ca2+]i as well as spasm in both middle
cerebral and basilar arteries (Haddock and Hill, 2002; Navarro-Gonzalez
et al., 2009; Yuill et al., 2010). Reducing extracellular calcium diminished
the amplitude of oscillations, led to relaxation and paradoxically
depolarized the membrane. The relaxation presumably reﬂected the
reduction in peak Em associated with the reduced amplitude of
oscillations in Em. Some small oscillations in tension did persist and
may reﬂect vasomotion-independent intracellular calcium release, as
reported in some arterial beds: for review see Haddock and Hill (2005).
As oscillations were insensitive to the calcium-dependent Cl− channel
inhibitor, DIDS and the voltage-dependent Na+ channel blocking agent,
tetrodotoxin they certainly appeared to be mediated exclusively by
calcium conductance. These data contrast with the basilar artery, where
inhibition of Cl− channels in this larger artery abolished calcium-
dependent oscillations, leading to hyperpolarization and relaxation
(Haddock and Hill, 2002) and parenchymal arterioles, where calcium-
dependent oscillations were blocked with tetrodotoxin (Filosa et al.,
2004). However, our data are consistent with human pial arteries, where
Fig. 5. Original traces showing (A) the effect of the voltage-gated K+channel inhibitor, 4-AP (3 mM) and (B) the effect of the Na+/K+-ATPase inhibitor, ouabain (1 μM) on
simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Average data are shown in (C) showing the oscillation amplitude inmembrane potential
(left panel) and tension (right panel) in control vessels and in the presence of ouabain and ouabain+4-AP. Data expressed as means±S.E.M. */+ P≤0.05 indicates a signiﬁcant
difference from either control or from ouabain alone, respectively, using one-way ANOVA with Tukey's post-hoc test, n=3.
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(Gokina et al., 1996). In the present study, oscillations in muscle
membrane potential were also resistant to direct damage of the
endothelium, suggesting that this monolayer may not inﬂuence rapid
vasomotion associated with arterial spasm.
In the rat middle cerebral artery, opening L-type Ca2+ channels is
essential for vasoconstriction and vasomotion to develop, because
inhibition of these channels abolishes vasomotion and fully reverses
tone (Yuill et al., 2010). Surprisingly, in the present study under similar
vasospastic conditions, oscillations in Em, and the associated oscillations
in tension were abolished and followed by relaxation after calcium
inﬂux through T-type Ca2+ channels was blocked with mibefradil (at a
concentration selective for block of T-type Ca2+ channels; 100 nM) or
with a T-type Ca2+ channel selective, non-hydrolysable analogue of
mibefradil, NNC 55-0396, (Huang et al., 2004). Block of oscillationswith
the putative T-type Ca2+ channel blockerswas not associatedwith a net
hyperpolarization and complete relaxation, contrastingwith the L-TypeCa2+ channel blocker nifedipine. So the effect of mibefradil or NNC 55-
0396 is unlikely to reﬂect a non-speciﬁc effect against L-type channels.
Furthermore, although mibefradil apparently reduced blood pressure
andmyogenic toneby anactionon L-type calciumchannels (Moosmang
et al., 2006), the lower concentration of mibefradil used in the present
study is relatively speciﬁc against T-type Ca2+ channels. In fact,
mibefradil seems only to inhibit the L-type Ca2+ channels after tissue
metabolism (Wu et al., 2000). The non-hydrolysable analogue of
mibefradil NNC 55-0396 is selective for T-type Ca2+ channels, with no
reportedblockof L-typeCa2+ channels even in concentrations ashighas
100 μM (Huang et al., 2004). Mibefradil has also been reported to block
both Cl− (Bernd et al., 1997) and Na+ (Eller et al., 2000; Guatimosim
et al., 2001) channels, but again with much higher concentrations
(μM) than employed in the current study. Furthermore, the fact that
blockers such as DIDs and TTX had no effect against vasospastic
vasomotion makes an action of mibefradil against these channels
extremely unlikely. Therefore, the differential effect of mibefradil
158 A.J. McNeish et al. / Vascular Pharmacology 53 (2010) 151–159and NNC-0396 compared to the selective blocker L-type Ca2+
channel blocker nifedipine indicates a critical role for T-type Ca2+
channels in vasospastic vasomotion. Further, these channels con-
tribute signiﬁcantly to the overall constriction in the middle cerebral
artery.
Vasospastic vasomotion only developed once the smooth muscle
cells depolarized to circa −40 mV, so it may be that T-type channels
involved in vasomotion have gating properties similar to high voltage
activated Ca2+ channels. This is surprising, as by deﬁnition T-type Ca2+
channels activate at low potentials and then quickly inactivate
(Lacinova, 2005). However, our data are consistent with studies
reporting T-type Ca2+ channels that inﬂuence vascular tone and have
properties similar to high voltage activated Ca2+ channels, (Navarro-
Gonzalez et al., 2009). Both T- and L-typeCa2+channels are expressed in
rat basilar (Navarro-Gonzalez et al., 2009) and middle cerebral arteries
(Kuo et al., 2008), and in each artery the CaV3.2 (or T-type) is the most
abundant VGCC alpha subunit expressed. Human recombinant T-type
Ca2+ channels (Kaku et al., 2003) and T-type Ca2+ channels co-
expressed with auxiliary subunits (Wyatt et al., 1998) do have gating
properties similar to high voltage activated channels, so channels in the
middle cerebral artery may be similar. Peripheral arteries also contain
VGCCs with similar biophysical properties to high voltage activated
channels (−50 to −20 mV), and are pharmacologically indistinguish-
able from T-type Ca2+ channels in both the guinea-pig and rat (Morita
et al., 1999; Morita et al., 2002). In these small mesenteric arteries, T-
type Ca2+ channels are the predominant voltage-gated subtype
(Gustafsson et al., 2001; Jensen et al., 2004), and show increased
window current due to non-inactivation at physiological Em (Jensen and
Holstein-Rathlou, 2009).
As nifedipine abolished vasomotion, we propose that L-type
channels are key for the initial depolarization and constriction (Yuill
et al., 2010); whereas T-type are activated subsequently and as such is
critical for the vasospastic vasomotion. Interestingly, input from T-type
Ca2+ channels seems to be important for the initial constriction in the
basilar artery, whereas L-type channels are critical for vasomotion
(Navarro-Gonzalez et al., 2009). But taken together, these results all
suggest a functional coupling between L- and T-type Ca2+ channels, as
previously suggested in renal (Hansen et al., 2001) and mesenteric
arterioles (Braunstein et al., 2008). As such, this might explain why
neuroprotection in ischemic stroke is more effective in patients given
blockers for more than just L-type VGCCs (Kobayashi and Mori, 1998).
As VGCC and hence vasospastic vasomotion are inhibited by a
complex interaction betweenNO and smoothmuscle cell BKCa channels
in middle cerebral arteries, we attempted to characterize further the
vasospastic vasomotion. Endothelial cell damage did not affect the
vasomotion, so we inhibited a variety of K+ currents. Both inwardly
rectifying and voltage-gated K+ channels participate in maintenance of
resting membrane potential and vascular tone (Ko et al., 2008; Nelson
andQuayle, 1995 Sobey, 2001).However, inhibitionofKIR channelswith
CsCl or barium did not affect vascular tone, although CsCl did slightly
increase Em oscillation amplitude. As Ba2+waswithout effect, this small
change most likely reﬂected a non-selective action of CsCl. Inhibition of
Kv channelswith 4-AP also had little effect, causing only a small increase
in the amplitude of oscillations in Em and tension. This is consistentwith
the reported role of these channels in rat mesenteric artery where
inhibition of Kv increased rhythmic contractions (Gustafsson and
Nilsson, 1994). So voltage-gated K+ channels did not appear to play
any major role in vasospastic vasomotion.
Our data do suggest that Na+/K+-ATPase might contribute to
vasomotion, as ouabain caused relaxation and reduced the amplitude
and frequency of oscillations in Em, although surprisingly without
affecting oscillations in tension. Ouabain can attenuate intercellular
communication in smooth muscle (Harris et al., 2000; Martin et al.,
2003; Matchkov et al., 2007) and the synchronized changes in vascular
[Ca2+]i (Koenigsberger et al., 2004) that lead to vasomotion (Chaytor
et al., 1997; Matchkov et al., 2004; Peng et al., 2001). So in part, ouabainmay alter membrane potential oscillations by modifying cell–cell
communication. Interestingly, ouabain effects were reversed by 4-AP,
again indicating that KV might contribute under some conditions to
inﬂuence vasomotion.
The ability of the KCa3.1 channel inhibitor TRAM-34 to reduce rather
than enhance the amplitude of oscillations in Em and tension was also
unexpected. This effect was on the smoothmuscle, as it was not altered
by removal of the endothelium, and in contrast to TRAM-34,
charybdotoxin, a mixed BKCa and KCa3.1 inhibitor failed to modify the
oscillations. One explanation is that TRAM-34 inhibits non-selective
cation channels in the smooth muscle, similar to its action in isolated
immune cells (Schilling and Eder, 2007). Non-selective cation channels
are present in ratmiddle cerebral artery smoothmuscle cells and appear
to contribute to the calcium entry and vascular tone (Marrelli et al.,
2007; Welsh et al., 2002). So data with TRAM-34 suggest that non-
selective cation channels may play an important role in the calcium
entry events underpinning depolarization and vasomotion after NOS
inhibition in the middle cerebral artery.
In summary, inhibition of either BKCa channels and/or NOS evokes
vasospasm and fast, rhythmic oscillations in Em and tension that are
mediated by Ca2+ inﬂux via both T-type and L-type Ca2+ channels. Our
data suggest that the T-type channels are active at physiologically
relevant membrane potentials and can therefore make an important
contribution to the control of cerebrovascular blood ﬂow during
vasospasm associated with disease states where NO synthesis or action
is impaired, such as cerebral ischemia or subarachnoid haemorrhage.
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